Table of contents
Clínica Tambre is set to participate in Fertility 2025, the 18th Annual Fertility Congress, taking place from January 8th to 11th, 2025, in Liverpool, UK. The clinic will present two scientific papers at the event. The first paper examines whether lower-quality embryos from donor eggs have higher implantation potential than better-quality embryos from a patient’s own eggs. The second paper explores embryo development through a morphokinetic analysis based on sperm selection methods, utilizing CHLOE, an advanced artificial intelligence (AI) analysis tool.
Reproduction: Facts, Myths, and Evidence
This congress, which Tambre attends every year, is organised by the Association of Reproductive & Clinical Scientists, the British Fertility Society, and the Society for Reproduction and Fertility. This year’s theme is “Reproduction: Facts, Myths, and Evidence”.
Latest Findings
Fertility 2025 will bring together leading global experts in the field of reproduction, who will share their latest findings and innovative techniques that could revolutionise fertility research and treatments. The programme will include plenary sessions, presentations of current research, and updates on the latest developments in reproductive science.
Tambre will present its scientific papers in poster format at the congress. Senior embryologist, Carolina Andrés, who leads both studies, and José Antonio Horcajadas, scientific advisor, will be attending to present the findings, accompanied by Tambre’s CEO, Inge Kormelink.
Attending Fertility 2025 will allow us to engage with leading fertility experts, enabling us to further enhance our knowledge and provide increasingly effective treatments. We will also gain valuable insights into the latest research and emerging trends shaping the future of reproductive medicine, allowing us to keep innovating and adapting to the needs of each of our patients. This congress will reinforce our commitment to remaining an international leader in fertility, ensuring that every patient receives the most advanced and personalised care throughout their journey to parenthood.
Cutting-Edge Treatments
Tambre’s participation in this prestigious international event highlights our commitment to excellence and innovation in reproductive medicine. Presenting two papers at such a relevant forum provides an opportunity to share knowledge, build collaborations, and stay at the forefront of scientific and clinical advances in fertility.
Foundation
The Fundación Tambre plays a key role in this process. It is the driving force behind research and scientific progress in the field of assisted reproduction. Through the foundation, we promote scientific studies that allow us to offer more innovative and effective treatments to our patients. The foundation collaborates with universities, companies, and experts in the field, enabling us to remain at the cutting edge of fertility advancements.
It is thanks to this research-driven work that papers like those presented at international congresses such as Fertility 2025 are created, showcasing new technologies and methods—such as artificial intelligence—to enhance embryo and sperm selection.
The Fundación Tambre promotes research and professional training, ensuring that our entire team is equipped with the most advanced knowledge to offer the best possible treatments to those who trust their reproductive health to the Tambre team.
